Josiane Prophiro

Dr. Josiane Prophiro

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2024 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
SBSandra Bonfante
Sandra Bonfante
MNMartins Back Netto
Martins Back Netto
AJAloir Neri de Oliveira Junior
Aloir Neri de Oliveira Junior
KMKhiany Mathias
Khiany Mathias
RMRichard Simon Machado
Richard Simon Machado
FPFabricia Petronilho
Fabricia Petronilho

Verified
Journal Article
Open access
PDF file
JOJOICE GUILHERME DE OLIVEIRA
JOICE GUILHERME DE OLIVEIRA
SNSergio Netto
Sergio Netto
EFEdenilson Osinski Francisco
Edenilson Osinski Francisco
CVCaroline Pereira Vieira
Caroline Pereira Vieira
PVPaula Fassicolo Variza
Paula Fassicolo Variza
JPJosiane Prophiro
Josiane Prophiro
In Brazil, the mosquito Aedes (Stegomyia) aegypti is considered the main vector of the dengue, chikungunya, and Zika arbovirus transmission. Recent epidemiological studies in southern Brazil have shown an increase in the incidence of dengue, raising concerns over epidemiological control, monitoring, and surveys. Therefore, this study aimed at performing a historical spatiotemporal analysis of the Ae. aegypti house indices (HI) in southern Brazil over the last 19 years. As vector infestation was associated with climatic and environmental variables, HI data from the Brazilian Ministry of Health, climate data from the Giovanni web-based application, and environmental data from the Mapbiomas project were used in this study. Our results showed an expressive increase in the number of HI surveys in the municipalities confirming the vector presence, as compared to those in 2017. Environmental variables, such as urban infrastructure, precipitation, temperature, and humidity, were positively correlated with the Ae. aegypti HI. This was the first study to analyze Ae. aegypti HI surveys in municipalities of southern Brazil, and our findings could help in developing and planning disease control strategies to improve public health.

23 October 2018 in Cells
Verified
Journal Article
Open access
PDF file
RGRafaelli De Souza Gomes
Rafaelli De Souza Gomes
KLKELY LIMA
KELY LIMA
VMValter Monteiro
Valter Monteiro
AOAna Lígia de Oliveira
Ana Lígia de Oliveira
DRDávila Valentina Silva Rodrigues
Dávila Valentina Silva Rodrigues
MMMarta Monteiro
Marta Monteiro
Sepsis is a systemic disease with life-threatening potential and is characterized by a dysregulated immune response from the host to an infection. The organic dysfunction in sepsis is associated with the production of inflammatory cascades and oxidative stress. Previous studies showed that Aedes aegypti saliva has anti-inflammatory, immunomodulatory, and antioxidant properties. Considering inflammation and the role of oxidative stress in sepsis, we investigated the effect of pretreatment with salivary gland extract (SGE) from Ae. aegypti in the induction of inflammatory and oxidative processes in a murine cecum ligation and puncture (CLP) model. Here, we evaluated animal survival for 16 days, as well as bacterial load, leukocyte migration, and oxidative parameters. We found that the SGE pretreatment improved the survival of septic mice, reduced bacterial load and neutrophil influx, and increased nitric oxide (NO) production in the peritoneal cavity. With regard to oxidative status, SGE increased antioxidant defenses as measured by Trolox equivalent antioxidant capacity (TEAC) and glutathione (GSH), while reducing levels of the oxidative stress marker malondialdehyde (MDA). Altogether, these data suggest that SGE plays a protective role in septic animals, contributing to oxidative and inflammatory balance during sepsis. Therefore, Ae. aegypti SGE is a potential source for new therapeutic molecule(s) in polymicrobial sepsis, and this effect seems to be mediated by the control of inflammation and oxidative damage.

9 March 2022 in Acta Tropica
Verified
Journal Article
Closed access
JOJOICE GUILHERME DE OLIVEIRA
JOICE GUILHERME DE OLIVEIRA
HJHarry Luiz Pilz Júnior
Harry Luiz Pilz Júnior
ALAlessandra Bittencourt de Lemos
Alessandra Bittencourt de Lemos
FCFelipe Allan da Silva da Costa
Felipe Allan da Silva da Costa
MFMillena Fernandes
Millena Fernandes
JPJosiane Prophiro
Josiane Prophiro

1 September 2021 in Acta Tropica
Verified
Journal Article
Closed access
JPJosiane Prophiro
Josiane Prophiro
MSMario Antonio Navarro da Silva
Mario Antonio Navarro da Silva
JOJOICE GUILHERME DE OLIVEIRA
JOICE GUILHERME DE OLIVEIRA
PVPaula Fassicolo Variza
Paula Fassicolo Variza
ALAlessandra B. de Lemos
Alessandra B. de Lemos
OSOnilda Santos da Silva
Onilda Santos da Silva

24 September 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
SSSamara Souza Stork
Samara Souza Stork
CSClaudia Meurer Souza
Claudia Meurer Souza
JPJosiane Prophiro
Josiane Prophiro
EBElizabeth A. Brownell
Elizabeth A. Brownell
Betine Pinto Moehlecke IserBetine Pinto Moehlecke Iser
Betine Pinto Moehlecke Iser
Background: Gestational diabetes mellitus (GDM) is the main cause of hyperglycemia in pregnancy and is related to complications throughout the gestational and post-partum period. Objectives: To analyze the pregnancy outcomes related to the occurrence of GDM in women and their offspring. Methods: Third-trimester pregnant women were interviewed and monitored until childbirth. The diagnosis of GDM, blood glucose ≥ 92 mg/dL, was defined by the criteria of the International Association of the Diabetes and Pregnancy Study Groups (IADPSG). Results: A total of 138 women participated, and there were 136 births (due to 2 fetal losses); 23 (16.7%) were diagnosed with GDM. The risk of complications during childbirth was higher among pregnant women with GDM (RR 3.40; 95%CI 1.65–7.00), as was the occurrence of cesarean birth (RR 1.9; 95%CI 1.46–2.59). The occurrence of preterm birth did not show a significant difference between GDM/non-GDM groups. There was a non-significant association in adjusted analyses of macrosomia (birth weight ≥ 4000 g) among newborns born to mothers with GDM (RR 1.27; 95%CI 0.67–2.38). For newborns born to pregnant women with GDM, there was a higher risk for the following outcomes: large for gestational age (LGA) (3.29 95%CI 1.62–6.64), low Apgar (4.98 95%CI 2.32–10.69), and birth asphyxia (9.51 95%CI 3.42–26.48). Conclusions: The findings reinforce that GDM is an important risk factor for adverse pregnancy outcomes for women and their offspring.